D
Nektar Therapeutics NKTR
$0.8968 $0.08149.98%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue 5.53% 6.17% 1.51% -2.10% -7.13%
Total Other Revenue -- -- -- -- --
Total Revenue 5.53% 6.17% 1.51% -2.10% -7.13%
Cost of Revenue -8.33% 50.39% 50.74% 56.08% 51.72%
Gross Profit 13.69% -11.70% -16.08% -19.97% -24.41%
SG&A Expenses -6.22% -5.15% -11.14% -16.15% -19.99%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -2.00% -3.75% -11.22% -32.18% -42.62%
Operating Income 6.57% 9.58% 18.19% 43.71% 53.42%
Income Before Tax 42.10% 41.72% 57.26% 24.31% 35.98%
Income Tax Expenses -100.30% -102.74% -105.68% -106.22% 4,337.31%
Earnings from Continuing Operations 42.69% 42.30% 57.61% 25.03% 35.34%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 42.69% 42.30% 57.61% 25.03% 35.34%
EBIT 6.57% 9.58% 18.19% 43.71% 53.42%
EBITDA 4.35% 7.48% 16.62% 43.92% 54.47%
EPS Basic 46.09% 44.63% 58.36% 26.08% 36.36%
Normalized Basic EPS 10.43% 14.53% 23.99% 38.70% 50.60%
EPS Diluted 46.18% 44.72% 58.41% 26.17% 36.26%
Normalized Diluted EPS 10.43% 14.53% 23.99% 38.70% 50.60%
Average Basic Shares Outstanding 6.17% 4.06% 1.90% 1.53% 1.60%
Average Diluted Shares Outstanding 6.17% 4.06% 1.90% 1.53% 1.60%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings